Arnatar Therapeutics, a California-based biotech startup, has launched with $52 million in series A funding to develop RNA-based therapies. The com...
Recent research has highlighted significant neurological abnormalities in COVID-19 patients, attributed to microglial dysfunction in the brain. The...
Argenx has announced positive results from its ADAPT SERON trial for Vyvgart (efgartigimod), a treatment for generalized myasthenia gravis (gMG). T...
Regeneron is preparing to file for FDA approval of cemdisiran, a therapy for generalized myasthenia gravis (gMG), following positive phase 3 trial ...
A recent study published in Alzheimer's & Dementia suggests that omega-3 fatty acids may help reduce the risk of Alzheimer's disease in women. Rese...
Scientists at St. Jude Children's Research Hospital have discovered that the protein midkine plays a preventative role in Alzheimer's disease by in...
A recent study published in the journal Alzheimer's & Dementia has identified a potential link between omega-3 fatty acid levels and Alzheimer's di...
Harvard Medical School researchers have identified lithium deficiency in the brain as a potential early trigger for Alzheimer's disease. Published ...
A new study published in Alzheimer's & Dementia suggests that women with Alzheimer's disease have lower levels of omega-3 fatty acids in their brai...
Generative AI is making significant strides in the fields of healthcare and space medicine. In the context of Parkinson's disease, AI is being util...